Houlihan Financial Resource Group’s AstraZeneca AZN Stock Holding History

Houlihan Financial Resource Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$35K	Buy	+300	New	+$33.4K	0.02%	195

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Houlihan Financial Resource Group's AZN Position: Q3 2020 in Review

Houlihan Financial Resource Group opened a new position in AstraZeneca (AZN) in Q3 2020: 300 shares worth $35K. The stake represents 0.02% of the portfolio and ranks #195 among its holdings.

722 funds tracked by Wall St. Rank hold AZN as of Q3 2020.

Houlihan Financial Resource Group held 300 shares of AstraZeneca worth $35K as of Q3 2020.
AstraZeneca was a new Houlihan Financial Resource Group position in Q3 2020.
AstraZeneca made up 0.02% of Houlihan Financial Resource Group's portfolio in Q3 2020, its #195 holding.
722 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2020.

Based on Houlihan Financial Resource Group's 13F filing for Q3 2020, filed 13 Nov 2020.